579 results
Page 5 of 29
6-K
EX-99.1
kb0xau0 6j
26 Oct 16
Collaboration Features First Integration of The Weather Company data with IBM Watson Health Cloud
12:00am
6-K
EX-99.1
z58jo10it dr4wac4q
20 Oct 16
Live Filing
12:00am
6-K
EX-99.1
8ez7v3ed723xsv
6 Oct 16
Teva and Celltrion Announce Exclusive Biosimilar Commercial Partnership
12:00am
6-K
EX-99.1
tbet0mr
20 Sep 16
Teva and Regeneron Announce Global Collaboration to Develop and Commercialize Fasinumab, an Investigational NGF Antibody for Chronic Pain
12:00am
6-K
EX-99.1
nizks94v840v
18 Aug 16
First Intravenous Anti-IL-5 Biologic Therapy for Severe Eosinophilic Asthma Now Approved in Europe
12:00am
6-K
9qtbhr
20 Jul 16
Current report (foreign)
12:00am
424B5
hqu8t3z8ubooz
18 Jul 16
Prospectus supplement for primary offering
12:00am
6-K
gp5442n bf
13 Jul 16
Current report (foreign)
12:00am
6-K
EX-99.1
v8usj
13 Jul 16
First Amendment to Master Purchase Agreement
12:00am
6-K
EX-99.1
p66soepe8adhkedq
10 Jun 16
Teva Announces Favorable Court Ruling in TREANDA® (bendamustine hydrochloride) Patent Infringement Litigation
12:00am
6-K
EX-99.1
ggjyxvman8a vs8a
18 Apr 16
First-HD Study shows improvements in Total Motor Score and Swallowing Function in Huntington disease patients treated with SD-809
12:00am
6-K
EX-99.1
es6q5b 26ynbbjs0iori
12 Apr 16
Teva to Present Data Highlighting Company’s Pipeline in Neurological Disorders at 68th AAN Annual Meeting
12:00am
6-K
pazpd wymj
30 Nov 15
Current report (foreign)
12:00am
424B5
2xi5f7s1dkb5x
30 Nov 15
Prospectus supplement for primary offering
12:00am
6-K
36xu9mikpb pivh7jtn
30 Nov 15
Current report (foreign)
12:00am
424B5
4w5io 07dp
30 Nov 15
Prospectus supplement for primary offering
12:00am
6-K
EX-99.1
0yx5jld
30 Sep 15
IMPORTANT NEW DATA FROM TEVA’S TEV-48125 PHASE 2b MIGRAINE PROGRAM PUBLISHED INLANCET NEUROLOGYIN BACK-TO-BACK ARTICLES
12:00am
6-K
EX-99.1
ic2 0iqyoti7kduc8
28 Sep 15
Teva Announces Approval of COPAXONE® in Japan for the Prevention of Relapse of Multiple Sclerosis
12:00am